Riskpilot← Back to searchSign inGet full accessAPOTEK SØM AS
ASActiveOrg 927164272Vardåsveien 69, 4637 Kristiansand SRetail sale of pharmaceutical products · NACE 4773Est. 20215 employees
Revenue 2024
NOK 15,3M
+14% vs 2023
EBITDA margin
-0.8%
-137% vs 2023
Equity ratio
14.6%
Financial strength
Net profit 2024
NOK -336K
-326% vs 2023
| Revenue | NOK 15,3M | +14% |
| EBITDA | NOK -123K | -137% |
| Net profit | NOK -336K | -326% |
| Total assets | NOK 3,5M | -21% |
| Equity | NOK 511K | -40% |
| Employees | 5 | — |
Legal name
APOTEK SØM AS
Org number
927164272
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
28. mai 2021
Share capital
NOK 830 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Drive apotek med salg av apotekvarer og dertil tilhørende tjenester.
Address
Vardåsveien 69, 4637 Kristiansand S
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 3 507 | 10 977 | 13 471 | 15 346 |
| Staff expenses | −864 | −1 875 | −2 358 | −2 990 |
| EBITDA | −310 | 326 | 336 | −123 |
| Depreciation & amort. | −51 | −133 | −133 | −133 |
| EBIT | −362 | 193 | 203 | −257 |
| Net financials | −0 | −1 | −22 | −73 |
| Profit before tax | −362 | 192 | 180 | −330 |
| Tax | −81 | 42 | 32 | 7 |
| Net profit | −281 | 150 | 149 | −336 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 3 909 | 2 960 | 4 404 | 3 486 |
| Equity | 549 | 698 | 847 | 511 |
| Long-term debt | 0 | 0 | 0 | 0 |
| Short-term debt | 3 360 | 2 261 | 3 557 | 2 975 |
| Total debt | 3 360 | 2 261 | 3 557 | 2 975 |
EBITDA margin
-0.8%
This company
15.8%
Market median
-105% vs market
20212024
Equity ratio
14.6%
This company
38.2%
Market median
-62% vs market
20212024
Return on equity
-65.9%
This company
18.4%
Market median
-458% vs market
20212024
Net profit margin
-2.2%
This company
8.1%
Market median
-127% vs market
20212024
Asset turnover
4.40×
This company
1.12×
Market median
+293% vs market
20212024
Debt / equity
5.83×
This company
0.62×
Market median
-840% vs market
20212024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-04-26 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KN Chief Executive Officer | Chief Executive Officer | 2025 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Chairman | 2021 | |
| Chairman | 2025 | |
| Board of Directors | 2021 | |
| Board of Directors | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 75% | 75% | 2023 | |
| Company | 25% | 25% | 2023 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Rfm Holding As
APOTEK SØM AS Board members of APOTEK SØM AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Khalid Nazeer | Chief Executive Officer | 0 companies |
| Minh Tam Thi Do | Chairman | 0 companies |
| Irshad Ahmad | Chairman | 0 companies |
| Johan Fredrik Balstad | Board of Directors | 0 companies |
| Dinh Phuc Vu | Board of Directors | 0 companies |